ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BIOM Biome Technologies Plc

4.50
0.00 (0.00%)
11 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biome Technologies Plc LSE:BIOM London Ordinary Share GB00B9Z1M820 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.50 4.00 5.00 4.50 4.50 4.50 0.00 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Manufacturing Industries,nec 6.98M -1.56M -0.0302 -1.49 2.32M
Biome Technologies Plc is listed in the Manufacturing Industries sector of the London Stock Exchange with ticker BIOM. The last closing price for Biome Technologies was 4.50p. Over the last year, Biome Technologies shares have traded in a share price range of 2.50p to 130.00p.

Biome Technologies currently has 51,555,814 shares in issue. The market capitalisation of Biome Technologies is £2.32 million. Biome Technologies has a price to earnings ratio (PE ratio) of -1.49.

Biome Technologies Share Discussion Threads

Showing 9476 to 9496 of 9925 messages
Chat Pages: Latest  385  384  383  382  381  380  379  378  377  376  375  374  Older
DateSubjectAuthorDiscuss
29/3/2021
20:23
I would say they have enough for the year if rf revenue doesn't pick up and steady increase in bioplastics revenue. We'll know more of the Q1 end position on 21st April.
jmf69
29/3/2021
20:12
Reported Group loss before interest, interest, taxation and amortisation (LBITDA) of £0.9m (2019: LBITDA of £0.5m), in line with market expectations, with Group operating loss of £1.6m

£1.6m is still a loss , to dress it up with Earnings before interest, taxes, depreciation and amortization basic means can off set in future profits hence the £0.9M

Just love accountancies

My worry is another cash call or sell RF Technologies as its dragging us down

thordon
27/3/2021
11:37
No that's incorrect. The group made a LBITDA of £0.9m. The LBITDA for Bioplastics was £0.1m, RF Technologies £0.4m and central costs £0.4m. Please read the finals.

With rapid growth from the Bioplastics division, and when the RF division's fortunes turnaround (which they will do, possibly more quickly than is currently expected) then you can see why this should get pretty exciting!

michaelmouse
27/3/2021
11:00
Whats interesting is in the interview is the Bio Plastic division made a 0.9 Million loss , which is much higher then i thought.
So the question is how much in the Bio Plastic division need to break even , be helpful if this could be calculated.
We could use the last 3 years accounts to get a rough figure ; any ideas will be helpful

thordon
26/3/2021
08:13
Latest DT interview with Paul Mines discussing final results:
ga_dti
25/3/2021
19:02
My take on the results today and outlook is that most of the revenue growth will come in H2 with the new product sales coming online. Still happy to hold. Gla.
jmf69
25/3/2021
11:59
From the allenby capital research note issued today...ValuationWith limited, if any, quoted companies operating in the same space as Biome and the current forecasted losses it is difficult to present a valuation based on traditional metricssuch as PER and EV/EBITDA. However, our belief that the shares are undervalued is supported on an analysis of the EV/Sales of smaller companies within the Chemicals sector that on average show a ratio of 4.2x for Year 1 forecasts and 4.1x for Year 2. On this basis and applying a sizeable discount of around 25% we arrive at a share price of around 750p which we believe is a reasonable short to medium term target (the shares reached a peak of 645p in January 2019) that would value the business on an EV/Sales of 3.2x 2021 forecasts and 2.3x for 2022
jmf69
25/3/2021
11:36
New Non-exec seems to be a heavier weight than a small co. like Biome would normally attract. I wonder what the thinking is - massive expansion on the cards? or getting the decks ready to be taken over?
heeley3
25/3/2021
10:55
hi amt - agree with your conclusion that limited downside and huge upside.
though the risk reward may not suit all.

all IMHO , DYOR + BoL
BIOM is in my portfolio

thirty fifty twenty
25/3/2021
10:35
Biome Bioplastics utilises industrial biotechnology developments to create bioplastics to replace oil-based polymers with biobased and biodegradable aromatic polyesters. https://t.co/9rAOlus6GJ #innovation #lifesciences #sustainable https://t.co/DYFr5j3Msl
jmf69
25/3/2021
10:28
But at what price?
jmf69
25/3/2021
10:14
Something about the price action seems wrong to me.On the figures & the recent RNS I can so no genuine reason for the rise.Wouldn't surprise me if it got taken out by some larger body & Mines can then head off into the sunset with a lump sum in his pocket & maintain his delusions of having done a good job.New non-execs etc might just be positioning of appropriate parties.Wouldn't be surprised to see plenty of PR fluff in the near future if I'm right.
begorrah88
25/3/2021
09:35
Yes I reckon based on current trends a loss of about 0.8m this year and cash outflow of about the same leaving 900k in the bank.
Then 2022 break even and cash neutral.
In H2 cash burn was only 400k so maybe my 800k for 2021 is pessimistic given probably 2m more in sales of Bio products.
There could of course be some major contracts and the furnace business might start to recover.
Anyway relatively safe at the moment with a huge opportunity further down the road. I am holding on.

amt
25/3/2021
08:42
Yep , think this year still heading for a loss with next year heading to profit
thordon
25/3/2021
07:57
Cash burn last year was £1.4m after p;acing
zipstuck
25/3/2021
07:45
Can't see BIOM holding on to its recent gains with these results.
hatfullofsky
25/3/2021
07:20
Biome Technologies plc announces its audited Final Results for the year ended 31 December 2020.

Highlights:

Final Results

· Another strong year for the Bioplastics division with revenue growth of 65% building on the 81% revenue growth achieved in 2019. The division enters 2021 with a healthy pipeline of customer positions and prospects.

· RF Technologies division revenues reduced to £0.8m due to the ongoing over-capacity in the division's core fibre optics manufacturing market.

· Reported Group loss before interest, interest, taxation and amortisation (LBITDA) of £0.9m (2019: LBITDA of £0.5m), in line with market expectations, with Group operating loss of £1.6m (2019: loss of £1.0m).

· Group cash position as at 31 December 2020 was £1.7m (31 December 2019: £2.1m) with no debt.

thordon
24/3/2021
20:13
sorry above was meant for ecr message board
johncasey
24/3/2021
20:12
37% drop from highs...id say its a bargain now with £4m in the bank
johncasey
24/3/2021
19:42
Good find.
marmar80
24/3/2021
11:25
I hear what you're saying and agree to a certain extent. I have been invested for quite a few years but almost at break-even unlike other long term holders. The only thing I would say is the market has changed massively in the last 10 years and customers as well as companies are looking for environmentally friendly products. Biome fits the bill and should see consistent growth in the coming years.
jmf69
Chat Pages: Latest  385  384  383  382  381  380  379  378  377  376  375  374  Older